ReviewAngiogenesis2021
TAK1 signaling is a potential therapeutic target for pathological angiogenesis.
Linxin Zhu et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
34 papers cite it
this papercites it
ReviewAngiogenesis2021
Linxin Zhu et al.PubMed ↗Publisher ↗
No numbers read from the abstract.